Atlas Trials

Study Evaluating the Efficacy of Eculizumab in the Treatment of Gemcitabine-induced Thrombotic Microangiopathies

Clinical trial NCT05702996 · WITHDRAWN

Trial details

NCT number
NCT05702996
Sponsor
University Hospital, Rouen
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Thrombotic Microangiopathies
Start date
2023-03-01
Primary completion
2025-09-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.